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based on a simple change in color or pH, as was done
used to provide modified natural products for drug
for screening hydantoinases or carotenoids [12–13], or
development. To enzymatically bridge the gap be- based on a halo around a bacterial colony when investi-
tween what is possible in aglycon biosynthesis and gating proteases [14]. To circumvent these limitations,
sugar derivatization, glycosyltransferases are the tools we made use of two highly homologous GTs, UrdGT1b
of choice. To overcome limitations set by their intrinsic and UrdGT1c, both involved in urdamycin biosynthesis
specificities, we have genetically engineered the protein (Figure 1) and sharing a 91% identical amino acid se-
regions governing nucleotide sugar and acceptor sub- quence, nevertheless transferring different activated
strate specificities of two urdamycin deoxysugar gly- deoxysugars to different acceptors. Previous work re-
cosyltransferases, UrdGT1b and UrdGT1c. Targeted vealed that one particular protein region, amino acids
amino acid exchanges reduced the number of amino (aa) 52–82, with an 18 amino acid difference between
acids potentially dictating substrate specificity to ten. both parents (Figure 2A), is responsible for both nucleo-
Subsequently, a gene library was created such that tide sugar and acceptor substrate specificity of these
only codons of these ten amino acids from both paren- GTs [15]. Thus, we could well confine the region to be
tal genes were independently combined. Library mem- engineered. Both parent genes/enzymes originate from
bers displayed parental and/or a novel specificity, with the urdamycin producer Streptomyces fradiae Tu¨2717
the latter being responsible for the biosynthesis of and belong to GT family 1, according to the CAZy classi-
urdamycin P that carries a branched saccharide side fication [16, 17]. UrdGT1c strictly accepts dNDP-L-rho-
chain hitherto unknown for urdamycins. dinose and transfers it via an -(1-3)-glycosidic bond to
the C-3 hydroxyl of D-olivose, while UrdGT1b transfers
Introduction D-olivose to the C-4 hydroxyl group of L-rhodinose,
forming a -(1-4)-glycosidic bond [18]. The present work
Facing cancer or multiresistant bacterial pathogenes, demonstrates that engineering natural product GTs can
the search for new compounds has become a major fuse, alter, or disconnect their donor sugar-, acceptor
issue in the pharmaceutical and medical sciences. The substrate-, and acceptor position specificities to obtain
Streptomycetes, especially, with their diverse second- natural products with unnatural glycosylation patterns.
ary products, among them many glycosylated com-
pounds, have attracted researchers’ attention. Since Results
glycosylation often provides an essential factor for phar-
Reduction of the Number of Amino Acidsmacologcial activity [1, 2], glycosides promise to be a
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Figure 1. Late Glycosylation Steps during
Urdamycin Biosynthesis
Steps catalyzed by UrdGT1b/UrdGT1b-like
enzymes and UrdGT1c/UrdGT1c-like en-
zymes are indicated in blue and red, respec-
tively. The novel mode of glycosylation is
shown in green.
for a HPLC-based screening procedure. The following tions. The library was prepared in Escherichia coli, and
chimeric genes were expressed in S. fradiae mutants.GTs were constructed to further constrict the relevant
enzyme portion. GT-DH1, GT-DH2, and GT-DH3 are To assess GT specificity, we made use of two S. fradiae
mutant strains. The first strain, S. fradiae AX [18], pro-UrdGT1b derivatives but carry residues of UrdGT1c ori-
gin within the specificity-conferring region: GT-DH1 car- duces aquayamycin (Figure 1), which is the acceptor
substrate for UrdGT1c. The second strain, S. fradiaeries 80Pro-Ala-Pro82, GT-DH2 additionally carries Val76,
and GT-DH3 carries 80Pro-Ala-Pro82 and 68Gly-Pro-Asp- XTC [15], provides the acceptor substrate for UrdGT1b,
12b-derhodinosyl-urdamycin G (Figure 1).Gln71 (Figure 2A). The presence of enzymes GT-DH1,
GT-DH2, and GT-DH3 in mutant S. fradiae AX did not A total of 400 S. fradiae AX and 198 S. fradiae XTC
transformants were screened for their urdamycin pro-influence glycosylation. Contrastingly, gene expression
in S. fradiae XTC resulted in the production of mainly duction spectrum by TLC and HPLC. Once an altered
pattern was found for one host, the plasmid with the12b-derhodinosyl-urdamycin A (Figure 1) in all cases.
These results indicate that the enzymes GT-DH1, GT- functional GT gene library member was reisolated for
DNA sequencing. In addition, it was used to transformDH2, and GT-DH3, respectively, are fully active, like
UrdGT1b, and that the amino acid changes did not affect the alternative host strain to check whether an additional
enzyme activity had been obscured due to the intrinsictheir specificity at all. GT-DH4 is perfectly identical with
GT-DH3 at the protein level but carries in its gene a metabolite pattern of the first host strain. The screening
revealed 40 different chimeric GTs. Basically, they splitunique AvrII site to facilitate further library engineering.
In its enzymatic properties, GT-DH4 is identical to GT- up into two main categories: GTs with parental enzy-
matic specificity (single or combined), and those cata-DH3, so it also represents an UrdGT1b-type enzyme.
Thus, the key to which glycosyltransfer will be performed lyzing a novel glycosylation mode, also single or com-
bined with one or both parental specificity.should be found among these remaining ten amino
acids.
GTs with Parental Specificity
Three library members were shown to act like the paren-Construction and Expression of a GT Library
To gain further insight into the role of these ten amino tal UrdGT1b-type enzyme GT-DH4, i.e., the enzyme
specificity had been retained. From ten amino acids inacids, a family of urdGT1b/1c chimeric GT genes was
created by a PCR-based approach. It was carried out question, Asn52, Asp55, and 58His-Val-Asp-Asp-Met62
are conserved in these three GTs. A complete switch-such that the codons responsible for these ten amino
acids were independently built in, while all other codons over into a strictly UrdGT1c-like enzyme was accom-
plished five times. Three of the ten amino acids in ques-remained unchanged, compared to the template gene,
GT-DH4. For an independent build-in, 11 nucleotide po- tion were found to be constant; these are Asn52, Lys62,
and Leu64. Three GTs displayed both parental activities,sitions must be variable. Each position can be occupied
by two nucleotides, thus allowing 211 2048 combina- depending on the acceptor substrate provided. In the
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Figure 2. Wild-Type and Engineered Glycosyltransferases
(A) Positioning of the specificity-conferring region (aa 52–82) within the enzymes UrdGT1b (blue arrow) and UrdGT1c (red arrow) and sequence
alignment including the parental wild-type enzymes and GT-DH1-4.
(B) Amino acid combinations of selected library members. Only the engineered protein region (aa 52–64) is shown.
presence of aquayamycin (in mutant S. fradiae AX), pended to yield 12b-derhodinosyl-urdamycin A. Re-
markably, two consecutive rounds of enzymatic activity,L-rhodinose was added to yield 12b-derhodinosyl-urda-
mycin G. In the presence of 12b-derhodinosyl-urda- i.e., a direct conversion from aquayamycin to 12b-
derhodinosyl-urdamycin A in S. fradiae AX, have nevermycin G (in mutant S. fradiae XTC), D-olivose was ap-
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been observed; although, the product of the first round all possible enzyme activities. As for the sequence,
GT0101 (which includes UrdGT1b activity) differs onlycould have served as an acceptor in the second. In
these three dual active GTs, neither activity dominates in Asn52 and Asp55 from GT0207 (Ser52 and Ala55),
which is void of UrdGT1b-like activity. Apparently, onesignificantly, and one amino acid, Asp55, is conserved
throughout. or both amino acids integrate an UrdGT1b-type mode of
action into the enzyme. Also, GT1577 possesses Trp56,
while GT1304 with Arg56 lacks UrdGT1b-like activityGTs with Novel Specificity
(Figure 2B, Table 2). Estimated by HPLC peak areas,Engineering GTs created enzymes that transfer D-oli-
urdamycin P production dominated 12b-derhodinosyl-vose within the 12b-derhodinosyl-urdamycin G mole-
urdamycin A biosynthesis in all five cases. However,cule to the C-4 hydroxy group of D-olivose, forming a
with a ratio of 1:0.6 GT0101 was found to balance best
-(1-4)-glycosidic bond. This new glycosylation mode
between both glycosylation products (HPLC-chromato-yields urdamycin P (Figures 1 and 3A), carrying a
gram shown in Figure 3B).branched saccharide chain that is a feature so far un-
known for urdamycins. NMR data of urdamycin P are
given in Table 1; additional support for the urdamycin P Discussion
structure arises from fragmentation experiments (Figure
3C). Surprisingly, with 28 members, the novel active GTs Glycosyltransferases with a new enzyme specificity
made up the largest group in this screening. It can be were generated by genetic engineering. The novel glyco-
subdivided into those with exclusively novel activity (2); sylation mode resulted in a branched saccharide origi-
those integrating a second activity, UrdGT1b (1) or nating from hydroxyl groups at C-3 and C-4 of the carrier
UrdGT1c (21); or those displaying triple activity (5). GTs sugar, a structural feature that also appears, for exam-
1707 and 1717, both with solely new activity, were found ple, in saccharomicins [19] or in calicheamicins as a
in the screening. It is intriguing that one of them, GT1717, branch via sugar atoms C-2 and C-4 [20]. An urdamycin
differs only in Ser56 from an UrdGT1c-type enzyme derivative carrying merely a diolivosyl side chain has
(GT1446), with arginine at this position (Figure 2B). With not been found in the screening. Thus, we conclude that
GT0204, a GT fusing UrdGT1b-like and new specificity the sugar side chain of 12b-derhodinosyl-urdamycin G
was found, and it differs at positions 53 (Val instead of is a prerequisite for the novel glycosylation mode and
Ile) and 61 (Asp instead of Ala) from GT 1707 (Figure that attachment of L-rhodinose to C-3 of the C-glycosidi-
2B), which lacks GT1b-like activity. With 21 examples, cally linked D-olivose occurs prior to the novel glycosyl-
the most abundant GTs were those displaying new activ- ation.
ity combined with an UrdGT1c-like mode of enzymatic Crystallographic and computational investigations
action. Interestingly, five of them (e.g., GT1304, Figure identified GTs as two-domain enzymes [21]. It is as-
2B) accept aquayamycin as a substrate, i.e., the engi- sumed that the active site resides in a cleft between
neered enzyme acts twice on its acceptor substrate to these two domains. In the absence of solved crystal
convert it to urdamycin P. These five GTs invariably structures for the GTs described here, we speculate
possess a Gly59 and Leu64, combined with a Met62 that the recombined amino acids reside in perhaps a
four times. Although the target hydroxy group on C-4 substrate- or product-lodging loop or cavity close to
of D-olivose is already present in aquayamycin, 16 GTs the substrate binding sites inside the protein. Such loops
showed the UrdGT1c-type-, but not the novel activity, have been reported from several solved crystal struc-
when aquayamycin was offered as a substrate. In con- tures of GTs, for example, SpsA from Bacillus subtilis
trast, novel activity was exerted in these cases with 12b- [22], GnTI from rabbit [23], and others. These loops ap-
derhodinosyl-urdamycin G as an acceptor substrate. pear flexible and could play a role in preventing the
Among these 16 enzymes, none of the amino acids in nucleotide sugar from being hydrolyzed or, more likely,
question is fully conserved. Nevertheless, the Gly59- in substrate binding and in product release [21]. Once
Leu64 motif was found 12 times, and a Met62 has been the glycosyltransfer is accomplished (indicated by the
detected 13 times. nucleotide diphosphate being cleaved off the sugar),
the loop is altered structurally. Compared with other GTs
of streptomycete secondary metabolism, e.g., those ofTriple-Specific GTs
Five enzymes (GTs 1438, 1511, 1577, 1815, and 0101) the pathways for erythromycin [24, 25], daunorubicin
[26, 27], mithramycin [28, 29], oleandomycin biosynthe-were shown to act in a highly unspecific manner. In the
presence of aquayamycin (in mutant S. fradiae AX), GTs sis [30], and many more, the protein region investigated
during this study shows little conservation in length and1438, 1511, 1577, and 1815 were acting like UrdGT1c
producing 12b-derhodinosyl-urdamycin G. They showed sequence, presumably reflecting the individual steric
interactions for the particular glycoside molecule. Duenew and UrdGT1b-like specificity, using 12b-derhodino-
syl-urdamycin G (in mutant S. fradiae XTC) as an acceptor, to steric constraints, the ten amino acids in question,
and their positional equivalents in other GTs, could de-which resulted in parallel 12b-derhodinosylurdamycin A
and urdamycin P production. The fifth enzyme (GT0101, cide if a product fits in the loop and if it is being released
from the catalytic center to exit the enzyme. Recently,Figure 2B, Table 2) was able to convert aquayamycin
to urdamycin P in S. fradiae AX, and, in S. fradiae XTC, the crystal structure of GtfB, an UDP-glucosyltransfer-
ase involved in chloroeremomycin biosynthesis, hasit converted 12b-derhodinosyl-urdamycin G to urdamycin
P and 12b-derhodinosyl-urdamycin A simultaneously. been published [31]. A shallow pocket located within
the N-terminal protein domain facing the interdomainIn summary, this enzyme is most flexible and exhibited
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Figure 3. Chemical Analysis of Urdamycin P
(A and B) (A) Molecular structure and (B)
HPLC chromatograms of untransformed host
strains, S. fradiae mutants AX (I) and XTC (II)
as controls, and S. fradiae XTC expressing
GT0101 (III).
(C) This panel documents the fragmentation
pattern of urdamycin P after APCI-MS (nega-
tive mode). The m/z value range from 500–850
atomic mass units (amu) is shown. Signal in-
tensities are given as relative abundance. The
616.6 amu signal correlates to an urdamycin
P fragment lacking L-rhodinose, and the
600.6 amu signal correlates to a fragment
lacking D-olivose, whereas the 730.8 amu sig-
nal corresponds to the unfragmented mole-
cule. Major artificial follow-up products of ur-
damycin P and fragments generated during




Table 2. Amino Acids at the Ten Engineered Positions of AllTable 1. NMR Data for Urdamycin P in CD3OD




1H 13C Specificity Type GT # (Positions 52–64)
1 – n.o UrdGT1b 2–1 NV-DP-HVDDM-V
2 2.82 (d, 13) 52.9 3–24 NI-DR-HVDDM-V
2.67 (dd, 2.5, 13) 1734 NI-DP-HVDDM-L
3 – 77.4 UrdGT1c 6–13 NI-DS-NGEDK-L
4 2.04 44.5 1106 NI-AP-HGEDK-L
5 6.40 (d, 9.5) 145.7 1423 NI-AR-HVDDK-L
6 6.87 (d, 9.5) 117.8 1446 NV-DR-HVDDK-L
7 – n.o 1701 NV-DS-NGDAK-L
8 – n.o Novel 1707 NV-DS-HVDAM-L
9 – n.o 1717 NV-DS-HVDDK-L
10 7.85 (d, 7.5) 133.9 UrdGT1b  UrdGT1c 3–11 NI-DW-HVDAK-L
11 7.58 (d, 7.5) 119.5 1210 SV-DS-NVDDM-V
12 – n.o. 1548 NV-DR-NGDAM-L
3 Me 1.24 (s) 29.8 Novel  UrdGT1b 0204 NI-DS-HVDDM-L
1 4.86 72.0 Novel  UrdGT1c* 0207 SI-AS-HGDDM-L
2 2.59 (ddd, 2, 4.5, 12.5) 37.3 1304 NI-DW-HGDAM-L
1.29 1322 NV-DS-HGEDM-L
3 3.91 (ddd, 4.5, 9, 11) 73.8 1565 SI-AW-NGDDK-L
4 3.37 (t, 7) 82.2 1814 SI-DW-HGDAM-L
5 3.53 77.2 Novel  UrdGT1c 3–17 NV-AS-NVEAM-V
6 1.39 (d, 6) 18.7 3–19 NV-DS-NVEAM-L
1″ 4.93 (brd, 3) 93.7 6–19 SV-AS-HGDDK-L
2″ 2.00 24.5 9–1 NI-AS-HGDDM-L
1.35 0820 IV-AP-NGDAM-L
3″ 2.25 26.2 1111 NV-DW-HGEDK-L
1.62 (m) 1128 SI-AS-NVDAM-L
4″ 3.52 68.1 1141 NV-DW-NGDAM-V
5″ 4.59 (dq, 1.5, 6.5) 66.8 1413 SV-DP-HGDAK-L
6″ 1.14 (d, 6.5) 17.2 1416 SV-AS-HGDAM-L
1 4.74 (dd, 2, 9.5) 100.9 1574 SV-DP-HGDAM-L
2 2.23 40.6 1703 SI-AS-HGDAM-L
1.44 (dt 9.5, 12) 1709 NV-DS-HGDAM-L
3 3.51 71.8 1720 NV-DP-HGDAM-L
4 2.84 (t, 9) 78.3 1806 SF-DP-NGEAM-L
5 3.24 (dq, 9, 6) 73.1 1812 SV-DP-NGDDM-L
6 1.29 (d, 6) 18.3 Novel  UrdGT1b  UrdGT1c 0101 NI-DS-HGDDM-L
1438 SI-DS-NVDDM-L1H chemical shifts are referenced to CHD2OD at 3.31 ppm. For re-
1511 NV-DP-NGDDM-Lsolved signals, multiplicities and coupling constants (0.5 Hz) are
1577 NI-DR-HGDAM-Lgiven in parentheses. The other 1H chemical shifts are derived from
1815 NI-AW-HGDDM-V2D spectra. 13C chemical shifts are derived from a 2D 1H-13C correla-
tion spectrum (HMQC) and are referenced to CHD2OD at 48.9 ppm. The category marked by an asterisk comprises those novel 
(n.o.  signal not observed). UrdGT1c-type enzymes that also accept aquayamycin as a sub-
strate.
cleft has been proposed as an acceptor substrate bind-
ing site. Two leucine residues are central to the pocket, mutations performed concurrently with the GtfB crystal-
lization work, Asp332 was identified as a potential mem-surrounded by six tyrosine or phenylalanine residues
plus three alanines and a cysteine. We found that none ber of the GtfB catalytic apparatus [31]. Interestingly,
the adjacent amino acids are strongly conserved amongof these residues that are crucial in GtfB are conserved
within UrdGT1b/1c, except Tyr122 (which is Tyr110 in GtfB and UrdGT1b/1c (327Leu-Pro-Gln-Met-Ala-Asp-
Gln333 in GtfB, and 311Leu-Pro-Gln-Leu-Ala-Asp-Gln317 inUrdGT1b/1c). The six aromatic residues are part of the
GtfB region comprising aa 122–190. The equivalent pro- UrdGT1b). Therefore, further work on UrdGT1b/1c could
include crystallization to obtain a clearer picture abouttein part in the GTs described here, however, comprises
only one tyrosine and phenylalanine each. In turn, those the role of this residue and whether wild-type and chi-
mera involve the same catalytic base.amino acid positions detected to be relevant to specific-
ity of UrdGT1b/1c have not been found to interact with Possibly due to structural flexibility, certain amino
acid combinations favor a particular activity withoutat least the acceptor substrate of GtfB. Observation of
the nucleotide-bound sugar within the crystals is ex- strictly dictating it. Unlike what is reported for a donor
substrate of human blood group GTs [32], we demon-tremely difficult; therefore, little is known about particu-
lar side chain interactions. Thus, it still seems possible strated that substrate range is not dictated by a single
amino acid residue or position. As has been shown dur-that GtfB residues, so far not recognized as being impor-
tant for sugar substrate acceptance, have their counter- ing this study, various amino acid combinations result
in an identical pattern of enzymatic specificity. However,part amino acid within the region investigated during
this study. In kinetic studies into a number of pinpoint almost all rhodinose-transferring GTs possess Leu64,
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pUWL201 [40]. Streptomyces protoplast preparation, transforma-and when additionally integrating novel or novel and
tion, and regeneration were done as described [41].UrdGT1b activity, Gly59 and Leu64 were found almost
throughout. GTs with UrdGT1b activity (single or in com-
Construction of Edited Glycosyltransferase Genes GT-DH1,
bination) almost always combine Asp60 and Met62. With GT-DH2, GT-DH3, and GT-DH4
about 7% active library members, the protein structure Gene GT-DH1 was constructed by PCR using primers M13 reverse
subjected to engineering seems to be vulnerable against and P1 to alter codons 80–82 of urdGT1b (Pro-Ala-Pro is encoded
instead of Ala-Ser-Leu). P1: 5-CGCCCGCTCGAGACGCGTCCGCamino acid substitution, and none of the engineered
GGCCGGCGCCTGAGTCGATGGGCGGG-3; the XhoI site is indi-GTs performed better than the wild-type enzymes, ac-
cated in bold. The template for the construction of GT-DH1 wascording to HPLC-peak area comparison. Nevertheless,
pUC18 with the urdGT1b cloned into the HindIII and BglII sites. PCR
the investigated region appears to be flexible enough to conditions were: 7 min at 97C; 30 cycles at 95C for 90 s, at 49C
tolerate nonparental amino acids in functional enzymes, for 60 s, and at 72C for 60 s; followed by a terminal hold at 72C
i.e., Ser and Arg on position 56 due to the construction for 10 min. The PCR product was cleaved with XhoI and BglII to
replace the equivalent sequence in plasmid pUC-urdGT1b, fromprocedure, or Phe53 and Ile52, possibly due to a PCR
which the original sequence had been removed, to generate plasmiderror in GT1806 and GT0820, respectively (Table 2).
pUC-DH1. The altered gene was excised with HindIII/XbaI and li-For numerous applications, rational design or directed
gated into pUWL201 to create plasmid pUWL-DH1. Gene GT-DH2
evolution approaches have proved to be a promising and plasmids pUC-DH2/pUWL-DH2 were constructed as described
strategy [33–36]. For natural product derivatization, this for GT-DH1, but using primer P2 (5-GAGCGCCCGCTCGAGGT
class of enzymes provides particularly versatile tools, GCGTCCGCGGCCGG-3), pUC-DH1 as the PCR template, and re-
striction enzymes XhoI (bold) and BglII to insert the PCR productsince they account for specific structural changes with
into gene GT-DH1, lacking the equivalent sequence, resulting inconsequences on bioactivity and could close the gap
gene GT-DH2. PCR conditions were: 7 min at 97C; 30 cycles atbetween glycorandomized sugar synthesis [37] and a
95C for 90 s, at 62C for 60 s, and at 72C for 60 s; followed by a
vast number of polyketide-derived aglycons. terminal hold at 72C for 10 min. Additionally, to the pinpoint muta-
tions of GT-DH1, GT-DH2 carries a codon for valin on position 76,
instead of threonine. Gene GT-DH3 and plasmids pUC-DH3/pUWL-Significance
DH3 were constructed as described for GT-DH1, but using primers
M13 universal and P3 (5-GGACGCACCTCGAGCGGCCGCTGA
Genetic engineering of the enzyme regions responsi- TCCGGCCCCAACCCGGCGACCAAC-3), pUC-DH1 as a PCR tem-
ble for selecting sugar and acceptor substrates in ur- plate, and enzymes XhoI (bold) and HindIII to insert the 0.25-kb
PCR product into gene GT-DH1, lacking the equivalent sequence,damycin GTs UrdGT1b and UrdGT1c has provided GTs
resulting in gene GT-DH3. PCR conditions were the same as thosewith combined and/or novel specificity, leading to a
used for GT-DH2. Additionally, to the pinpoint mutations of GT-DH1,new urdamycin derivative with an unusual branched
GT-DH3 carries codons for Gly-Pro-Asp-Gln, instead of Arg-Glu-
saccharide side chain. This study should stimulate fur- Gly-Glu, on positions 68–71. Glycosyltransferase gene GT-DH4 was
ther investigations on GTs as valuable tools for drug constructed as described for DH3, but using primer P4 (5-
derivatization and lead compound generation as well GTCTCGAGCGGCCGCTGATCCGGCCCTAGGCCGGCGACCAAC-
3), pUC-DH3 as a PCR template, and enzymes HindIII and NotIas rational saccharide design. With critical hot spots
(bold) to insert the PCR product into gene GT-DH3, lacking thenow being located, saturation mutagenesis could
equivalent sequence, resulting in gene GT-DH4. This gene carriesopen up new possibilities for engineering new speci-
silent mutations in codons 66 (Gly) and 67 (Leu) (GGGTTG in GT-
ficities into GTs. From the mechanistic point of view, DH3 now replaced by GGCCTA in GT-DH4), thus generating a unique
it is intriguing that different amino acid combinations AvrII site (underlined).
account for the same substrate spectrum and that
minor changes in the amino acid sequence enable or Construction of a Library of Positionally Shuffled
Glycosyltransferase Genesdisable an additional catalytic activity. These findings
Primers F: 5-GATCCGGCCCTAGGCCGGCGASCAACWTGKCSTCmight give an impetus for comparing crystallization or
CMCGTKGAACSRGKCGCCGAYGYTCACCGCGTTGAGC-3, and R:computational studies to unveil further how GTs work
5-AGAGAAGGCCTAGGGCCGGATCAGCGGCCGCTCGAGGTGCG
in respect to substrate choice and product release. TCCGCGGC-3 (AvrII site in bold) were used for PCR; the template
plasmid was pUC-DH4. The primers maintain the AvrII site of GT-
DH4, overlap there, and are oriented divergently. Thus, the entireExperimental Procedures
template plasmid was amplified by PCR. PCR conditions were: 7
min at 96C; 35 cycles at 95C for 60 s, at 56C for 50 s, and at 72CGrowth Conditions, Media, and Genetic Manipulation
for 2 min; followed by a terminal hold at 72C for 7 min, also usingof Streptomyces fradiae
Taq DNA polymerase. The PCR product was cut with AvrII andFor screening purposes, transformants were fermented in miniature
ligated to constitute proper circular plasmids. Then, they wereculture vessels, each filled with 7 ml NL 111 V liquid medium [18]
corestricted with HindIII and XbaI to remove the diversified genes,supplemented with 25 	g/ml thiostrepton and kept at 250 rpm for
which subsequently were ligated into pUWL201 and used to trans-96 hr at 28C. For urdamycin P production, strain S. fradiae XTC 
form S. fradiae mutants AX and XTC protoplasts.GT0101 was grown as a seed culture for 48 hr in a 500-ml single-
baffled erlenmeyer flask filled with 100 ml medium at 180 rpm and
28C. This culture was then used to inoculate the main culture (1% Metabolite Screening
A total of 1 ml culture broth was extracted with an equal volume ofv/v), which was fermented for 60 hr. All DNA manipulation was
carried out in Escherichia coli XL-1 blue MRF’ (Stratagene) following ethyl acetate. The organic layer was evaporated, redissolved in
methanol, and subjected to TLC and HPLC analysis. TLC was carrieddescribed procedures [38] and the instructions of the suppliers of
enzymes and reagents (Promega, Pharmacia). Before transforming out on silica gel 60 F254 plates; the solvent was chloroform/methanol/
ethyl acetate (8:1:1, v/v). HPLC was done using a Hewlett-PackardS. fradiae mutants AX and XTC, the gene library and the constructs
carrying the edited genes were passed through E. coli ET12567 [39] HP1100 series integrated system. Chromatography was over a 3-	
Hypersil HyPurity Elite C18 column eluting at 1.0 ml/min.Solvent Ato obtain nonmethylated DNA. E. coli strains were grown under
standard conditions. Vector pUC18 was used for routine cloning was 10% acetonitrile in H2O and 10 mM ammonium acetate, and
solvent B was 90% acetonitrile in H2O and 10 mM ammonium ace-purposes. Gene expression constructs were based on vector
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tate. The gradient was 15%–90% B at 0–20 min; 90%–95% B at multiplasmid approach to preparing large libraries of polyke-
tides. Proc. Natl. Acad. Sci. USA 96, 11740–11745.20–21 min, held at this relation at 21–23 min; 95%–15% B at 23–24
min, held at 15% B at 24–27 min. The detection wavelength was 10. McDaniel, R., Thamchaipenet, A., Gustafsson, C., Fu, H., Bet-
lach, M., Betlach, M., and Ashley, G. (1999). Multiple genetic
  254 nm; UV-VIS spectra were recorded from 
  190–600 nm.
Rf values and retention times of these substances were determined modifications of the erythromycin polyketide synthase to pro-
duce a library of novel “unnatural” natural products. Proc. Natl.by comparison to those of authentic samples.
Acad. Sci. USA 96, 1846–1851.
11. Tang, L., Fu, H., and McDaniel, R. (2000). Formation of functionalExtraction, Isolation, and Chemical Analysis of Urdamycin P
heterologous complexes using subunits from the picromycin,A total of 4 liters of fermentation broth of S. fradiae XTC  GT0101
erythromycin and oleandomycin polyketide synthases. Chem.was extracted twice with an equal volume of ethyl acetate. After
Biol. 7, 77–84.evaporating the organic phase, the dry crude extract was dissolved
12. May, O., Nguyen, P.T., and Arnold, F.H. (2000). Inverting enantio-in 8 ml methanol and applied in equal portions to four preparative
selectivity by directed evolution of hydantoinase for improvedHPLC runs. The equipment used was a Gilson 306 solvent pump,
production of L-methionine. Nat. Biotechnol. 18, 317–320.a Gilson 118 UV-VIS detector, and a 5-	 Kromasil C8 column (250 
13. Schmidt-Dannert, C., Umeno, D., and Arnold, F.H. (2000). Molec-21.2 mm i.d.). Elution was at 15 ml/min with a gradient of 0%–60%
ular breeding of carotenoid biosynthetic pathways. Nat. Bio-B over 75 min, then held at 60% B for an additional 15 min. Solvent
technol. 18, 750–753.A was H2O (10 mM ammonium acetate), and solvent B was 80%
14. Ness, J.E., Welch, M., Giver, L., Bueno, M., Cherry, J.R., Bor-acetonitrile in H2O (20 mM ammonium acetate). Fractions containing
chert, T.V., Stemmer, W.P.C., and Minshull, J. (1999). DNA shuf-urdamycin P were bulked, diluted with an equal amount of water,
fling of subgenomic sequences of subtilisin. Nat. Biotechnol.and reapplied to the HPLC system/gradient described above. For
17, 893–896.a final workup, the urdamycin P fraction was adsorbed into a 500-
15. Hoffmeister, D., Ichinose, K., and Bechthold, A. (2001). Twomg Isolute Env cartridge (International Sorbent Technology). It
sequence elements of glycosyltransferases involved in urda-was washed with 10 ml H2O, then eluted with 10 ml methanol. About mycin biosynthesis are responsible for substrate specificity and4 mg urdamycin P was obtained. NMR spectra were recorded in
enzymatic activity. Chem. Biol. 8, 557–567.CD3OD on a Bruker AMX 500 spectrometer. Urdamycin P has a 16. Campbell, J.A., Davies, G.J., Bulone, V., and Henrissat, B. (1997).
molecular formula of C37H46O15; MW is 730.8, confirmed by atmo- A classification of nucleotide-diphospho-sugar glycosyltrans-
spheric pressure chemical ionization (APCI) mass spectrometry un-
ferases based on amino acid sequence similarities. Biochem.
der described conditions [42]. Production cultures of XTCGT0101
J. 326, 929–942.
yielded approximately 1 mg/l urdamycin P and 0.6 mg/l 12b-derhodi-
17. Coutinho, P.M., and Henrissat, B. (1999). Carbohydrate-Active
nosyl-urdamycin A. Background production of 12b-derhodinosyl-
Enzymes Server (http://afmb.cnrs.mrs.fr/pedro/CAZYdb.html).
urdamycin G, intrinsic to S. fradiae XTC, was about 3 mg/l.
18. Trefzer, A., Hoffmeister, D., Ku¨nzel, E., Stockert, S., Weitnauer,
G., Westrich, L., Rix, U., Fuchser, J., Bindseil, K.U., Rohr, J., et
Acknowledgments al. (2000). Function of glycosyltransferase genes involved in
urdamycin A biosynthesis. Chem. Biol. 7, 133–142.
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